Table 1. Demographic and clinical characteristics.
| All (n=175) | ESBL-E negative (n=151) | ESBL-E positive (n=24) | P-value | |
|---|---|---|---|---|
| Demographics | ||||
| Gender | ||||
| Male | 91 (52.0 %) | 80 (53.0 %) | 11 (45.8 %) | |
| Female | 84 (48.0 %) | 71 (47.0 %) | 13 (54.2 %) | 0.515 |
| Age (years) | ||||
| 6–11 | 113 (64.6 %) | 99 (65.6 %) | 14 (58.3 %) | |
| 12–16 | 62 (35.4 %) | 52 (34.4 %) | 10 (41.7 %) | 0.492 |
| Median age (IQR) years | 11 (9–12) | 11 (8–12) | 11 (9–13) | 0.291 |
| Current CD4 count (cells µl−1) | ||||
| <350 | 19 (10.9 %) | 15 (9.9 %) | 4 (16.7 %) | 0.325 |
| ≥350 | 156 (89.1 %) | 136 (90.1 %) | 20 (83.3 %) | |
| Median CD4 count (IQR) | 710 (468–952) | 710 (472–952) | 699 (409–944) | 0.548 |
| Current viral load (copies ml−1) | ||||
| ≤50 | 117 (66.8 %) | 101 (66.9 %) | 16 (66.7 %) | |
| >50 | 57 (32.6 %) | 49 (32.5 %) | 8 (33.3 %) | 0.948 |
| Missing | 1 (0.6 %) | 1 (0.7 %) | 0 (0.0 %) | |
| Duration on ART (months) | ||||
| ≤12 months | 10 (5.73 %) | 5 (3.3 %) | 5 (20.8 %) | 0.001 |
| >12 months | 165 (94.3 %) | 146 (96.7 %) | 19 (79.2 %) | |
| Median duration on ART (IQR) years | 4.6 (2.4–6.4) | 4.8 (2.7–6.4) | 3.5 (1.5–6.6) | 0.145 |
| Clinical characteristics | ||||
| Admitted to the hospital in last 12 months | ||||
| No | 166 (94.9 %) | 144 (95.4 %) | 22 (91.7 %) | |
| Yes | 9 (5.1 %) | 7 (4.6 %) | 2 (8.3 %) | 0.446 |
| Admitted to the hospital for a chest infection/pneumonia in last 12 months | ||||
| No | 171 (97.7 %) | 149 (98.7 %) | 22 (91.7 %) | |
| Yes | 4 (2.3 %) | 2 (1.3 %) | 2 (8.3 %) | 0.033 |